Fundraising FoxBioPharmX
Menlo Park, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into BioPharmX
Sign up to see every warm intro you have to BioPharmX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioPharmX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BioPharmX was founded in 2014 by Anja Krammer and JAMES PEKARSKY.
JP
JAMES PEKARSKYCEO and CFO
Board
MH
Michael HubbardChairman
SM
Stephen MorlockBoard director
Investors · 1
Korea Investment PartnersreportedSeoul · $3M – $10M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 7 of 8 rounds · 2012–2022
▶Undisclosed amountofferedOct 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶Undisclosed amountofferedOct 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LuccheseExecutive Officer
- Alan M. MendelsohnExecutive Officer
- Edward J. SitarDirector
- David E. CohenDirector
- Lubor GaalDirector
- John KoconisExecutive Officer, Director
- Gianluca PirozziDirector
- Placement agents
- H.C. Wainwright & Co. LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$930KraisedOct 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$930KraisedOct 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Greg KitchenerExecutive Officer
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Stephen MorlockDirector
- Offering amount
- $930K
- Amount sold
- $930K
- Sales commissions
- $55.8K
- Placement agents
- Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$508.5KraisedMar 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$508.5KraisedMar 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anja KrammerExecutive Officer, Director
- Kin ChanExecutive Officer
- Michael HubbardDirector
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Offering amount
- $508.5K
- Amount sold
- $508.5K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7.9MraisedMar 2015 · 51 investors · PharmaceuticalsRule 506(b)
▶$7.9MraisedMar 2015 · 51 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JAMES PEKARSKYExecutive Officer, Director
- PING WANGDirector
- ANJA KRAMMERExecutive Officer, Director
- KIN CHANExecutive Officer
- MICHAEL HUBBARDDirector
- Offering amount
- $18.6M
- Amount sold
- $7.9M
- Finders' fees
- $227.2K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
▶$134.3KraisedMar 2015 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- James PekarskyExecutive Officer, Director
- Kin ChanExecutive Officer
- Ping WangDirector
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Offering amount
- $134.3K
- Amount sold
- $134.3K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 05
▶$1.8MraisedMar 2015 · 25 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedMar 2015 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ping WangDirector
- James PekarskyExecutive Officer, Director
- Anja KrammerExecutive Officer, Director
- Michael HubbardDirector
- Kin ChanExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Aug 2012
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$7KraisedJan 2014 · 4 investors · PharmaceuticalsRule 506(b)
▶$7KraisedJan 2014 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- ANJA KRAMMERExecutive Officer, Director
- JAMES PEKARSKYExecutive Officer, Director
- Offering amount
- $7K
- Amount sold
- $7K
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2010
- Federal exemptions
- 06b
▶$500KraisedJan 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- JAMES PEKARSKYExecutive Officer, Director
- ANJA KRAMMERExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded BioPharmX?
- BioPharmX was founded by Anja Krammer, JAMES PEKARSKY in 2014.
- Who are BioPharmX's investors?
- BioPharmX's investors include Korea Investment Partners.
- How much funding has BioPharmX raised?
- BioPharmX has disclosed $11.7M raised across 7 of its 8 known rounds.
- Where is BioPharmX headquartered?
- BioPharmX is headquartered in Menlo Park, US.